Figures
Abstract
Introduction
Hypertension is a major public health problem globally and it is a leading cause of death and disability in developing countries. This review aims to estimate the pooled prevalence of hypertension and its determinants in Ethiopia.
Methods
A systematic literature search was conducted at the electronic databases (PubMed, Hinari, and Google Scholar) to locate potential studies. Heterogeneity between studies checked using Cochrane Q test statistics and I2 test statistics and small study effect were checked using Egger’s statistical test at 5% significance level. Sensitivity analysis was checked. A random-effects model was employed to estimate the pooled prevalence of hypertension and its determinants in Ethiopia.
Results
In this review, 38 studies that are conducted in Ethiopia and fulfilled the inclusion criteria with a total number of 51,427 study participants were reviewed. The overall pooled prevalence of hypertension in the country was 21.81% (95% CI: 19.20–24.42, I2 = 98.35%). The result of the review also showed that the point of prevalence was higher among males (23.21%) than females (19.62%). When we see the pervasiveness of hypertension from provincial perspective; the highest prevalence of hypertension was observed in Addis Ababa (25.35%) and the lowest was in Tigray region (15.36%). In meta-regression analysis as the mean age increases by one year, the likelihood of developing hypertension increases by a factor of 0.58 times (β = 0.58, 95% CI: 0.31–0.86, R2 = 36.67). Male sex (OR = 1.29, 95% CI: 1.03–1.61, I2 = 81.35%), age > 35 years (OR = 3.59, 95% CI: 2.57–5.02, I2 = 93.48%), overweight and/or obese (OR = 3.34, 95% CI: 2.12–5.26, I2 = 95.41%), khat chewing (OR = 1.42, 95% CI: I2 = 62%), alcohol consumption (OR = 1.50, 95% CI: 1.21–1.85, I2 = 64%), family history of hypertension (OR = 2.56, 95% CI: 1.64–3.99, I2 = 83.28%), and family history of diabetes mellitus (OR = 3.69, 95% CI: 1.85–7.59, I2 = 89.9%) are significantly associated with hypertension.
Conclusion
Hypertension is becoming a major public health problem in Ethiopia. Nearly two out of ten individuals who are older than 18 years living with hypertension. Sex, age, overweight and/or obese, khat chewing, alcohol consumption, and family history of hypertension and diabetes mellitus are statistically significant determinant factors for hypertension in Ethiopia. Primary attention should be given for behavioral risk factors to tackle the alarming increase of hypertension in Ethiopia.
Citation: Tiruneh SA, Bukayaw YA, Yigizaw ST, Angaw DA (2020) Prevalence of hypertension and its determinants in Ethiopia: A systematic review and meta-analysis. PLoS ONE 15(12): e0244642. https://doi.org/10.1371/journal.pone.0244642
Editor: R. Jay Widmer, Baylor Scott and White, Texas A&M College of Medicine, UNITED STATES
Received: January 16, 2020; Accepted: December 14, 2020; Published: December 31, 2020
Copyright: © 2020 Tiruneh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting information files.
Funding: The author(s) received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Globally, more than 1.13 billion people living with hypertension, of this two-thirds living in Low and Middle-Income Countries (LMICs) [1]. In the globe, by the end of 2025 1.56 billion people will live with hypertension [2]. In Africa, 46% of adults whose age is older than 25 years and above living with hypertension [3]. The prevalence of hypertension in Africa has raised from 19.7% in 1990 to 30.8% in 2010 [4]. One in every five people live with hypertension in LMICs and studies showed that 3 out of 4 people in these countries will live with hypertension by the end of 2025 [5]. Besides, 74.7 million people living with hypertension in Sub-Saharan Africa, and it will rise to 125.5 million by the end of 2025 [6]. These trends have been strongly linked with lifestyle changes such as an increase in smoking tobacco use, excessive alcohol consumption, and physical inactivity [7, 8]. To tackle the burden of hypertension, the Pan-African Society of Cardiology (PASCAR) identified 10 action points to be implemented by African ministers to achieve a 25% decline by the end of 2025 [7, 9].
In Ethiopia, non-communicable diseases account for 39% of all causes of mortality of which, cardiovascular disease accounts for 16% [10]. On the other hand, hypertension constitutes the majority (62.3%) of all the causes of cardiovascular-related morbidity and mortality [11]. This is because high blood pressure increases the risk of life-threatening complications on vital organs like heart, blood vessels, brain, and kidney which leads to premature mortality and disability [12].
In 2015, a systematic review and meta-analysis was conducted in Ethiopia [13]; but this study did not identify the pooled effects of factors affecting the prevalence of hypertension. Besides, there are several studies published after the previous review. Therefore, this systematic review and meta-analysis gives updated pooled prevalence and factors affecting the prevalence of hypertension in Ethiopia.
Moreover, documenting the updated pooled prevalence and its determinants of hypertension will help to achieve the action plan of the Pan-African Society of Cardiology and global targets regarding hypertension. Therefore, the objective of this systematic review and meta-analysis is to synthesize updated pooled prevalence and its determinants of hypertension in Ethiopia. The finding of this review will show the trends of hypertension in Ethiopia and that can be used for health planners, policymakers, and for the community itself to curve the alarming rise of hypertension in Ethiopia.
Methods
Study setting and search strategies
Ethiopia is found in the horn of Africa and has nine administrative regional states and two city administrations. Potential studies were identified using electronic databases (PubMed/MEDLINE, Hinari, Google scholar) and google search. Besides, unpublished theses were also reviewed out from some research centers and library sources. The sources are reviewed limited to English language and studies published after 01/01/2000. The task of searching sources was carried out from all stated electronic databases performed on October/24/2019. All included studies defined hypertension as Systolic Blood Pressure (SBP) ≥ 140 mmHg and/or a Diastolic Blood Pressure (DBP) ≥ 90 mmHg or known hypertensive patients on treatment. The search MeSH headings were hypertension and synonyms for hypertension were used. The synonyms of hypertension are “blood pressure, high”, “and blood pressures, high”, “high blood pressure”, and “high blood pressures”. Finally, the search combination used as; “Hypertension” OR "Blood Pressure, High” OR "High Blood Pressure" OR "High Blood Pressures" OR "Blood Pressure, High" OR "Blood Pressures, High" AND Ethiopia (S1 Table).
Eligibility criteria
We used CoCoPop (Condition, Context, and Population) approach for prevalence studies to declare inclusion and exclusion criteria.
Inclusion criteria and exclusion criteria
Studies conducted on the prevalence and/or associated factors of hypertension in Ethiopia were included. Besides, all full-text articles written in English language (with response rate > 85%), with participants older than 18 years and published after January 01/2000 are included for this review. Studies conducted on pregnancy-induced hypertension, for the reason that has no prevalence report on hypertension, and hypertension prevalence reports on other comorbidities excluded for this review.
Measurement of the outcome variable
The primary outcome of interest for this review was to estimate the pooled prevalence of hypertension and its determinants. Potentials of extracted factors from each study considered as an independent factor for hypertension.
Study selection and data collection
All the studies reviewed through different electronic databases were combined, exported, and managed using Endnote version X9.2 (Thomson Reuters, Philadelphia, PA, USA) software. All duplicate studies were removed and full-text studies downloaded using Endnote software and manually. The eligibility of each study was completely assessed independently by two reviewers (SA. &YA.). Exaggerated differences in the results of the two reviewers narrowed through discussion and other reviewer members (ST. & DA.).
Assessment of the quality of the individual studies
The quality of the studies assessed using the validated modified version of a quality assessment tool for prevalence studies [14]. Two reviewers (SA. & YA.) were independently assessed to check the quality of the included studies. The problem of subjectivities between the two reviewers was solved through discussion and other review teams (ST. & DA.). The quality assessment tool has nine-questions. Based on the score of the quality assessment tool the highest score had the minimum risk of bias. Overall scores range from (0–3), (4–6), and (7–9), which are declared low, moderate, and high risk of bias respectively [14].
Data extraction and management
All-important parameters extracted from each study were reviewed by two authors (SA. &YA.) independently using Microsoft Excel. The discrepancies between the two authors managed through discussion and/or the other authors (ST. & DA.). The data extraction format was prepared using the assistance of the Joanna Briggs Institute (JBI) data extraction tool for prevalence studies. For each study, authors, years of publication, study design, sample size, the prevalence of hypertension with their standard error, and determinant factors effect size with their standard error were extracted.
Statistical analysis
The extracted data were exported to STATA/MP version 16.0 software for analysis. The pooled prevalence of hypertension and its determinants analyzed by the random effects model using DerSimonian-Laird model weight [15]. Heterogeneity in meta-analysis is mostly inevitable due to differences in study quality, its sample size, method, and different outcome measurements across studies [16, 17]. Statistically, significant heterogeneity was checked by Cochrane Q-test and I2 statistics [18]. To minimize the variance of estimated points between primary studies, a subgroup analysis was carried out in reference to the regions, age categories, and residence. Besides, a sensitivity analysis was also conducted to determine the influence of single studies on the pooled estimates. Univariate meta-regression conducted using year of publication, the mean age of the respondent from primary studies, sample size, and region using random effects model. Publication bias (small study effect) checked using graphically and Egger’s statistical test [19]. Statistically significant Egger’s test (P-value < 0.05) indicates that the presence of a small study effect and handled by non-parametric trim and fill analysis using the random effects model [20].
Results
Study selection and identification
Of the 784 studies reviewed, 336 were excluded, because they were duplications. By reading their titles and abstracts, 406 studies excluded as they were irrelevant for this review. Again, five studies excluded, because of the outcome not reported, inadequate sample size, and lack of full text. Finally, 38 potential studies have been included for qualitative and quantitative synthesis influences as summarized in the PRISMA flow diagram [21] (Fig 1).
Characteristics of included studies
Among the included studies, 20 (52.60%) studies published after 2016. All the included studies were cross-sectional surveys, of which 27 community based, six health facility-based, and five studies were institutional-based (Schools, College, Bank…). Overall, a total number of 51,427 study participants who are older than 18 years included for this review. The minimum and maximum sample sizes were 306 and 9788 respectively [22, 23]. A minimum of (7.47%) and maximum of (41.90%) prevalence of hypertension were reported from the studies conducted in the Oromia region [24, 25]. Five regions and two city administrations (Addis Ababa and Dire Dawa) were represented for this review. Seven from Amhara Region [26–32], eight from Oromia Region [24, 25, 33–38], six from South National and Nationalities of People’s Region (SNNPR) [22, 39–43], four from Tigray Region [44–47], three from Somali Region [48–50], eight from Addis Ababa [51–58], two from Dire Dawa [37] and one national study in Ethiopia [23] were included. No studies reviewed from Gambela, Afar, Benishangul Gumez, and Harari Regional states of Ethiopia (Table 1).
The pooled prevalence of hypertension in Ethiopia
In random effects model, the pooled prevalence of hypertension in Ethiopia was 21.81 (95% CI = 19.20–24.42); significant heterogeneity observed among studies (I2 = 98.4, P-value < 0.001). The highest weight among studies observed from the studies conducted by Muluneh et al. [37], Gebreyes et al. [23], and Birlew et al. [24] (Fig 2). Among 23 studies in the random effects model, the pooled prevalence of hypertension among males were 23.21 (95% CI:18.86–27.57) (Fig 3) with statistically significant heterogeneity (I2 = 97.5%, P-value < 0.001). Besides, the overall pooled prevalence of hypertension among females were 19.62 (95% CI: 16.26–22.97) (Fig 4); heterogeneity (I2 = 96.08%, P-value <0.001). Egger’s statistical test evidenced that has no publication bias among the included studies (β = -0.615, P-value = 0.91).
Handling heterogeneity
Significant heterogeneity observed from random effects model pooled estimate. To handle this heterogeneity sensitivity analysis, subgroup analysis, and meta-regression analysis were performed.
Sensitivity analysis
From the random effects model, there are no studies that excessively influence the overall pooled estimate of hypertension (S1 Fig).
Subgroup analysis
Even though subgroup analysis was carried out across the administrative regions of the country, age category, and residence as the source of heterogeneity was not handled. In the subgroup analysis, the highest prevalence of hypertension observed in Addis Ababa (25.35%) followed by Southern Nations Nationalities and People’s Region (23.83%); whereas the lowest prevalence was in Tigray regional state of Ethiopia (15.36%). The pooled prevalence of hypertension (27%) was higher in the age category which is older than 35 years. Also, the highest prevalence of hypertension was observed in urban inhabitants (22.85%) (Table 2).
Meta-regression
Univariate meta-regression analysis revealed that the mean age and region were statistically significant with hypertension. As the mean age increased by one year, the likelihood of developing hypertension increases by a factor of 0.58 times (β = 0.58, 95% CI: 0.31–0.86); with a total proportion of hypertension explained by the covariate mean age by 36.67% (adjusted R2 = 36.67). The linear relationship between mean age and hypertension was presented as shown in Fig 5 below. Besides, the pooled prevalence of hypertension was higher in the capital city of Addis Ababa, Ethiopia as compared to Tigray regional state of Ethiopia (β = 10.01, 95% CI: 1.22–18.80) (Table 3).
Factors associated with hypertension
As summarized in Table 4, sex, age, Body Mass Index (BMI), chat chewing, alcohol consumption, and family history of hypertension and diabetes mellitus were statistically significant factors for hypertension.
Fifteen [22, 24, 26, 28, 30, 31, 33, 41, 43, 46, 48, 51, 52, 54, 59] studies were included to identify the association between sex and hypertension. Five of these studies [22, 26, 28, 33, 59] had no statistically significant association between sex and hypertension. From random effects model estimate, the pooled odds of developing hypertension among males were 29% more likely to develop hypertension than females (OR = 1.29, 95% CI: 1.03–1.61); with statistically significant heterogeneity between studies (I2 = 81.3%, P-value < 0.001) (Fig 6). Egger’s test indicates that no small study effect (P-value = 0.544) and in random effects model there was no single study that excessively influences the pooled estimate of hypertension (S2 Fig).
The pooled effect of age has a significant association with hypertension. From fifteen [23, 24, 28, 30, 35, 40, 41, 46, 48, 50, 51, 52, 54–56] studies only one [24] study had no significant association between age and hypertension. The pooled odds of developing hypertension among individuals older than 35 years was 3.59 times higher than age younger than 35 years (OR = 3.59, 95% CI: 2.57–5.02) (Fig 7); with statistically significant heterogeneity among studies (I2 = 93.5%, P-value < 0.001). There is no small study effect (P-value = 0.485) and in random effects model, there was no single study excessively influence the pooled estimate of effect size (S3 Fig).
A total of eighteen [22, 25, 27–29, 31, 32, 35, 40, 43, 45–47, 49–51, 55, 56] studies included to estimate the association between BMI and hypertension. The results of the test statistics indicate that significant heterogeneity was observed between studies (I2 = 95.41%, P-value < 0.001). Egger’s test evidenced that there was no publication bias (P-value = 0.176). Again, from random effects model, no individual studies excessively influence the pooled estimate of the effect size (S4 Fig). From the random effects model pooled estimate, the likelihood of developing hypertension among overweight and/or obese individuals was 3.34 times higher than the normal-weight individuals (OR = 3.34, 95% CI: 2.12–5.26) (Fig 8).
The pooled effects between khat chewing and hypertension was assessed using ten studies [22, 24, 33, 35, 36, 46, 48, 49, 55, 57]. Among the included studies, six [22, 24, 33, 36, 38, 48] of them reported that khat chewing has not a statistically significant association with hypertension. Based on Egger’s test there was no publication bias (P-value = 0.498). Besides, from random effects model there was no single study that excessively influences the pooled effect size (S5 Fig). Khat chewers have 42% more likelihood to develop hypertension than non-khat chewers (OR = 1.42, 95% CI: 1.10–1.85) (Fig 9), with moderate heterogeneity (I2 = 62.2%, P-value = 0.005).
The association between alcohol consumption and hypertension was assessed using 14 studies [22, 24, 26, 27, 30, 34–36, 38, 55–57, 59]. Moderate heterogeneity was also observed from the random effects model (I2 = 64.04%) and there is no evidence of a single study that affects the pooled effects size in the sensitivity analysis (S6 Fig). Egger’s test evidenced that small study effect (P-value = 0.001). After non-parametric trim and fill analysis (Fig 10), alcohol consumption had a negative effect on hypertension. From the random-effects trim and fill analysis, alcohol drinkers were more likely to develop hypertension by half as compared to non-drinkers (OR = 1.50, 95% CI: 1.21–1.85).
A total of fifteen studies [22, 25, 26, 28, 29, 32, 33, 35, 41, 43, 45, 48, 49, 56, 59] were included to determine the association between physical activity and hypertension; of them, four studies had no statistically significant association with hypertension. From random effects model estimate, significant heterogeneity observed (I2 = 91.3%, P-value < 0.001). Egger’s test indicates that evidence of publication bias (P-value = 0.002). After non-parametric trim and fill analysis, physical exercise and hypertension has no significant association (OR = 1.24, 95% CI: 0.83–1.85).
As the results of eleven studies [22, 25, 29, 30, 33, 34, 43, 48–50, 55], family history of hypertension and hypertension had statistically significant association. The random effects model evidenced that statistically significant heterogeneity across studies (I2 = 83.3%, P-value < 0.001). From the sensitivity analysis random effects model estimate there is no single study that excessively influences pooled effect size (S7 Fig). Egger’s test showed that the presence of a small study effect (P-value = 0.016). After non-parametric trim and fill analysis pooled estimate (Fig 11), the pooled odds of developing hypertension among individuals who had a family history of hypertension were 2.56 times higher than their counterparts (OR = 2.56, 95% CI:1.64–3.99).
Furthermore, the association between the family of diabetes mellitus and hypertension was identified using nine studies [22, 23, 29, 32, 33, 48, 55, 56, 59]; among them, four studies [22, 23, 48, 59] showed that there is no statistically significant association between family history of diabetes mellitus and hypertension. The random effects model estimate showed that statistically significant heterogeneity between studies (I2 = 89.9%, P-value < 0.001) and Egger’s test showed that there is no publication bias (P-value = 0.47). From random effects model sensitivity analysis, there is no single study that excessively affects the pooled effect size (S8 Fig). Form random effects model estimate individuals who had a family history of diabetes mellitus are 3.69 times more likely to develop hypertension than the reference category (OR = 3.69, 95% CI: 1.85–7.59) (Fig 12) (Table 4).
Discussion
Non-communicable diseases are becoming a double burden of public health problem in developing countries [60]; besides hypertension prevalence is rising in developing countries in contrast to developed nations [61]. This systematic review and meta-analysis will give the update pooled estimates of hypertension in Ethiopia which gives invaluable information to policymakers, health planners, and the community itself.
This systematic review and meta-analysis revealed that the pooled prevalence of hypertension in Ethiopia was 21.81% (95% CI: 19.20–24.42), which was consistent with a study conducted in rural communities of Sub-Saharan Africa (22%), Kenya (22.8%), and a meta-analysis from Vietnam (21.1%) [62–64]. However, the finding of this meta-analysis was lower than the previous meta-analysis reports in LMICs (32.3%), among adults in Africa (57.0%), a meta-analysis study on undiagnosed hypertension in Sub-Saharan Africa (30%), Nigeria (28.9%), India (29.8%), Pakistan (26.34%), and a study in Nepal (25.1%) [65–71]. The prevalence of hypertension in this review was higher than a study conducted a previous systematic review in Ethiopia and a study conducted in Ghana [13, 72]. The possible reason for this discrepancy might be the time of the study, the age group of the population studied, the diagnosis criteria for hypertension, and the study setting.
From subgroup analysis by region, the highest prevalence of hypertension (25%) was observed in the capital city of Ethiopia, Addis Ababa. This is similar to subgroup analysis by the residence which is the prevalence of hypertension (23%) was higher in urban inhabitants. The possible justification might be, urbanization may be linked to low physical activity, consumption of unhealthy diet and stress which may again leads to the high burden of non-communicable diseases [73–76].
This review also identifies the determinant factors of hypertension. In random effects model pooled estimate, sex, age, body mass index, khat chewing, alcohol consumption, family history of hypertension, and family history of diabetes mellitus were significantly associated with hypertension.
From the random effects model estimate, the pooled odds of developing hypertension among males were 29% higher than females. This finding was similar with the studies conducted in Nepal, Varanasi India, Burkina Faso, Debrecen city of Hungary, and a meta-analysis study from Vietnam [62, 69, 77–80], whereas it is not similar to a study conducted at Uganda [81]. The possible reason might be males were more vulnerable to behavioral risk factors for hypertension.
The pooled effect of age greater than 35 years was 3.6 times higher than age less than 35 years to develop hypertension, which is similar to the community-based studies conducted in Uganda, Nepal, Benin, Varanasi city India, and another city of New Delhi, India [79–83]. As well, from meta-regression analysis showed that mean age and hypertension had a direct linear relationship. Age is one of the non-modifiable risk factors for hypertension. As a result, this is the fact that cardiovascular system is strongly affected by ageing; besides, ageing causes the structural and functional changes in the blood vessels that may lead to cardiovascular morbidity and mortality [84].
This review also evidenced that individuals being overweight and/or obese were venerable to hypertension. The likelihood of developing hypertension among overweight and/or obese individuals were three times higher than normal in their body mass index. This finding is similar to the previous studies conducted in different countries [63, 77–79, 81]. Besides, a study conducted in Japan evidenced that as 1 kg/m2 increase in body mass index increases the odds of developing hypertension by 23% among males and 35% among females [85]. This study strengths the fact that high body mass index increases blood cholesterol level which leads to hypertension [86]. Furthermore, this review evidenced that khat (Catha edulis) chewers were 42% more likely to develop hypertension than their counterparts which was similar to the studies conducted in Ethiopia, Yemen, and a meta-analysis study from Ethiopia [87–90]. Khat contains chemicals cathinone, cathine, and amphetamine. Cathinone is structurally related to amphetamine which increases levels of dopamine in the brain by acting on the catecholaminergic synapses [91] and increase blood pressure and heart rate [92, 93].
The pooled estimates of alcohol drinking and hypertension were statistically significant in random effects model estimate with moderate heterogeneity between studies. The odds of developing hypertension among drinkers were higher than by half as compared to non-drinkers. This finding was similar to the studies done in North American and France [94–96]. Another study evidenced that consuming three or more drinks of alcohol per day which approximately doubles the risk of developing hypertension [97]. Alcohol consumption affects the central nervous system which enhances cardiac output and has an effect on peripheral vascular effects [98].
Furthermore, family history of hypertension was a potential determinant factor for hypertension. Individuals who had a family history of hypertension have almost five times more chance to develop hypertension than individuals who had no family history of hypertension. This finding was similar to the previous studies conducted in China, Sri Lanka, and Mexico [99–101]. In addition, individuals who had a family history of diabetes mellitus were 3.7 times more likely to develop hypertension as compared to their counterparts. These factors are non-modifiable risk factors for hypertension. The possible association of family history of hypertension and diabetes mellitus with hypertension might be close blood relatives might have the same genes which may predispose to hypertension. Besides, close blood relatives might have experience of common behavioral practices that may predispose to hypertension.
This study follows some strengths and limitations. Our review adds considerable knowledge of the updated prevalence of hypertension in Ethiopia. All included studies use the same definition to declare hypertension. Subgroup analysis was performed to minimize statistical heterogeneity. Multiple factors were also included to identify the significant factors for hypertension. However, substantial statistically significant heterogeneity was observed across studies which undermine the pooled estimate of hypertension suggests that chance could be responsible for between-study variability. Sub-group analysis could not identify the source of heterogeneity. Though, meta-regression analysis suggested that mean age and region explain some source of heterogeneity.
Conclusions and recommendations
In conclusion, hypertension is becoming a major public health problem in Ethiopia. Nearly two out of ten individuals who are older than 18 years in Ethiopia are living with hypertension. The highest prevalence of hypertension was observed in Addis Ababa and the lowest was in Tigray region. Sex, age, overweight and/or obesity, chat chewing, alcohol consumption, family history of hypertension and family history of diabetes mellitus were statistically significant factors for hypertension. Based on the finding of this review, we recommend that health planners, policymakers, and the community itself should give prior attention to behavioral risk factors such as chat chewing, alcohol drinking and sedentary lifestyle.
Supporting information
S1 Table. Studies search strategies and entry terms from different electronic databases on the prevalence and determinants of hypertension.
https://doi.org/10.1371/journal.pone.0244642.s001
(DOCX)
S1 Fig. Sensitivity analysis plot for the pooled prevalence of hypertension.
https://doi.org/10.1371/journal.pone.0244642.s002
(TIF)
S2 Fig. Assessment of sensitivity analysis plot for factor sex.
https://doi.org/10.1371/journal.pone.0244642.s003
(TIF)
S3 Fig. Assessment of sensitivity analysis plot for the factor age.
https://doi.org/10.1371/journal.pone.0244642.s004
(TIF)
S4 Fig. Assessment of sensitivity analysis plot for factor among obese and/or overweight.
https://doi.org/10.1371/journal.pone.0244642.s005
(TIF)
S5 Fig. Assessment of sensitivity analysis plot for factor Khat Chewing.
https://doi.org/10.1371/journal.pone.0244642.s006
(TIF)
S6 Fig. Assessment of sensitivity analysis plot for factor alcohol consumption.
https://doi.org/10.1371/journal.pone.0244642.s007
(TIF)
S7 Fig. Assessment of sensitivity analysis plot for factor family history of hypertension.
https://doi.org/10.1371/journal.pone.0244642.s008
(TIF)
S8 Fig. Assessment of sensitivity analysis plot for factor alcohol consumption.
https://doi.org/10.1371/journal.pone.0244642.s009
(TIF)
References
- 1.
World Health Orgnaisation. Hypertension fact sheets. 2019. https://www.who.int/news-room/fact-sheets/detail/hypertension
- 2.
Olin BR, Pharm D. Hypertension: The Silent Killer: Updated JNC-8 Guideline Recommendations. 2018.
- 3. Haldar RN. Global Brief on Hypertension: Silent Killer, Global Public Health Crisis. Indian J Phys Med Rehabil. 2013;24: 2–2.
- 4. Adeloye D, Basquill C. Estimating the prevalence and awareness rates of hypertension in Africa: A systematic analysis. PLoS One. 2014;9. pmid:25090232
- 5.
van de Vijver S, Akinyi H, Oti S, Olajide A, Agyemang C, Aboderin I, et al. Status report on hypertension in Africa—Consultative review for the 6th Session of the African Union Conference of Ministers of Health on NCD’s. Pan Afr Med J. 2013;16: 1–17.
- 6. Ogah OS, Rayner BL. Recent advances in hypertension in sub-Saharan Africa. Heart. 2013;99: 1390–1397. pmid:23708775
- 7. Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global Ncd Target Reduce High Blood Pressure. Lancet. 2017;31: 190–215.1037//0033-2909.I26.1.78
- 8. Walker RW, McLarty DG, Kitange HM, Whiting D, Masuki G, Mtasiwa DM, et al. Stroke mortality in urban and rural Tanzania. Lancet. 2000;355: 1684–1687. pmid:10905244
- 9. Dzudie A, Rayner B, Ojji D, Schutte AE, Twagirumukiza M, Damasceno A, et al. Roadmap to achieve 25% hypertension control in Africa by 2025. Cardiovasc J Afr. 2017;28: 262–273. pmid:28906541
- 10.
WHO. NONCOMMUNICABLE DISEASES COUNTRY PROFILES 2018. Heart of Africa: Clinical Profile of an Evolving Burden of Heart Disease in Africa. 2016.
- 11. Tefera YG, Abegaz TM, Abebe TB, Mekuria AB. The changing trend of cardiovascular disease and its clinical characteristics in Ethiopia: Hospital-based observational study. Vasc Health Risk Manag. 2017;13: 143–151. pmid:28461753
- 12. Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global Ncd Target Reduce High Blood Pressure. Lancet. 2017;31: 190–215.1037//0033-2909.I26.1.78
- 13. Kibret KT, Mesfin YM. Prevalence of hypertension in Ethiopia: a systematic meta-analysis. Public Health Rev. 2015;36: 14. pmid:29450042
- 14. Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: Modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65: 934–939. pmid:22742910
- 15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7: 177–188. pmid:3802833
- 16. Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I 2 Index? Psychol Methods. 2006;11: 193–206. pmid:16784338
- 17. Thompson SG, Smith TC, Sharp SJ. Investigating underlying risk as a source of heterogeneity in meta-analysis. Stat Med. 1997;16: 2741–2758. pmid:9421873
- 18.
Green S and H JP. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Collaboration and John Wiley & Sons Ltd. Published. 2017.
- 19. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315: 629–634. pmid:9310563
- 20. Duval S, Tweedie R. A Nonparametric “Trim and Fill” Method of Accounting for Publication Bias in Meta-Analysis. J Am Stat Assoc. 2000;95: 89–98.
- 21. Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6. pmid:19621072
- 22. Kalssa Aschenaki, Ayele Gistane, Tamiso Alemu G T. Prevalence and Associated Factors of Hypertension among Civil Servants Working in Arba Minch Town, South Ethiopia. Int J Public Heal Sci. 2016;4: 375–383.
- 23. Gebreyes YF, Goshu DY, Geletew TK, Argefa TG, Zemedu TG, Lemu KA, et al. Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: Evidences from the National NCDs STEPS Survey, 2015. PLoS One. 2018;13: 1–18. pmid:29742131
- 24. Birlew T. Risk Factors for Hypertension among Adults. An Analysis of Survey Data on Chronic Non-Communicable Disease at Gilgel Gibe Field Research Center, South West Ethiopia. Sci J Public Heal. 2015;3: 281.
- 25. Shukuri A, Tewelde T, Shaweno T. Prevalence of old age hypertension and associated factors among older adults in rural Ethiopia. Integr Blood Press Control. 2019;Volume 12: 23–31. pmid:31564965
- 26. Abebe SM, Berhane Y, Worku A, Getachew A. Prevalence and associated factors of hypertension: a crossectional community based study in northwest ethiopia. PLoS One. 2015;10: e0125210. pmid:25909382
- 27. Belachew A, Tewabe T, Miskir Y, Melese E, Wubet E, Alemu S, et al. Prevalence and associated factors of hypertension among adult patients in Felege-Hiwot Comprehensive Referral Hospitals, northwest, Ethiopia: a cross-sectional study. BMC Res Notes. 2018;11: 876. pmid:30526686
- 28. Demisse AG, Greffie ES, Abebe SM, Bulti AB, Alemu S, Abebe B, et al. High burden of hypertension across the age groups among residents of Gondar city in Ethiopia: a population based cross sectional study. BMC Public Health. 2017;17: 647–649. pmid:28793889
- 29. Awoke A, Awoke T, Alemu S, Megabiaw B. Prevalence and associated factors of hypertension among adults in Gondar, Northwest Ethiopia: A community based cross-sectional study. BMC Cardiovasc Disord. 2012;12: 2–7. pmid:22292476
- 30. Kiber M, Wube M, Temesgen H, Woyraw W, Belay YA. Prevalence of hypertension and its associated factors among adults in Debre Markos Town, Northwest Ethiopia: community based cross-sectional study. BMC Res Notes. 2019;12: 406. pmid:31307528
- 31. Tadesse T, Alemu H. Hypertension and associated factors among university students in Gondar, Ethiopia: A cross-sectional study. BMC Public Health. 2014;14: 2–6.
- 32. Anteneh ZA, Yalew WA, Abitew DB. Prevalence and correlation of hypertension among adult population in Bahir Dar city, northwest Ethiopia: a community based cross-sectional study. Int J Gen Med. 2015;8: 175. pmid:26005357
- 33. Kebede Gudina E, Michael Y, Assegid S. Prevalence of hypertension and its risk factors in southwest Ethiopia: A hospital-based cross-sectional survey. Integr Blood Press Control. 2013;6: 111–117. pmid:23986649
- 34. Asresahegn Asfaw H. Effect of Shift-Work on Hypertension Among Factory Workers in Ethiopia. Am J Clin Exp Med. 2015;3: 142.
- 35. Bissa S, Mossie A, Gobena T. Prevalence of Hypertension and Its Association with Substance Use among Adults Living in Jimma. World J Med Med Sci. 2014;2: 1–11.
- 36. Bonsa F, Gudina EK, Hajito KW. Prevalence of hypertension and associated factors in Bedele Town, Southwest Ethiopia. Ethiop J Health Sci. 2014;24: 21–26. pmid:24591795
- 37. Muluneh AT, Haileamlak A, Tessema F, Alemseged F, Woldemichael K, Asefa M, et al. Population based survey of chronic non-communicable diseases at gilgel gibe field research center, southwest ethiopia. Ethiop J Health Sci. 2012;22: 7–18. pmid:23319836
- 38. Negera Ebissa, Sileshi Tesfaye H RB. MAGNITUDE and ASSOCIATED FACTORS OF HYPERTENSION AMONG ADULTS IN ILLUBABORE ZONE OF OROMIA NATIONAL REGIONAL STATE, SOUTH WEST ETHIOPIA,2016/17. INDO Am J Pharm Sci. 2018;05: 11549–11555.
- 39. Mara AM, Edris MM, Shikur A, Sintayew S. Magnitude of hypertension among adult residents in mizan-aman town, bench maji zone, Southwest Ethiopia–a descriptive cross-sectional study. MOJ Curr Res Rev. 2018;1: 148–152.
- 40. Esaiyas A, Teshome T, Kassa D. Prevalence of Hypertension and Associate Risk Factors among Workers at Hawassa University, Ethiopia: An Institution Based Cross Sectional Study. J Vasc Med Surg. 2018;6: 1–6.
- 41. Asfaw LS, Ayanto SY, Gurmamo FL. Hypertension and its associated factors in Hosanna town, Southern Ethiopia: community based cross-sectional study. BMC Res Notes. 2018;11: 306. pmid:29769149
- 42. Zekewos A, Egeno T, Loha E. The magnitude of hypertension and its risk factors in southern Ethiopia: A community based study. PLoS One. 2019;14: e0221726. pmid:31461475
- 43. Helelo TP, Gelaw YA, Adane AA. Prevalence and associated factors of hypertension among adults in durame town, Southern Ethiopia. PLoS One. 2014;9: 1–9. pmid:25415321
- 44. Mengistu MD. Pattern of blood pressure distribution and prevalence of hypertension and prehypertension among adults in Northern Ethiopia: disclosing the hidden burden. BMC Cardiovasc Disord. 2014;14: 33. pmid:24592854
- 45. Gebrihet TA, Mesgna KH, Gebregiorgis YS, Kahsay AB, Weldehaweria NB, Weldu MG. Awareness, treatment, and control of hypertension is low among adults in Aksum town, northern Ethiopia: A sequential quantitative-qualitative study. PLoS One. 2017;12: 1–16. pmid:28489865
- 46. Bayray A, Meles KG, Sibhatu Y. Magnitude and risk factors for hypertension among public servants in Tigray, Ethiopia: A cross-sectional study. PLoS One. 2018;13: e0204879. pmid:30281660
- 47. Zikru AB, Gebru HB, Kahsay AB. Prevalence and determinants of Hypertension among adult population in Mekelle city, Northern Ethiopia. Int J Innov Pharm Sci Res. 2014;2: 653–668.
- 48. Asresahegn H, Tadesse F, Beyene E. Prevalence and associated factors of hypertension among adults in Ethiopia: a community based cross-sectional study. BMC Res Notes. 2017;10: 628–629.
- 49. Seifu W. Behavioral Risk Factors of Hypertension among Pastoral and Agro Pastoral Adult Communities, Eastern Ethiopia, Somali Regional State, 2016. J Trop Dis. 2017;5.
- 50. Naba Tamene NO. Prevalence Of Hypertension And Associated Risk Factors Among Adult Population In Wolaita Sodo Town, Southern Ethiopia. Int J Med Res Pharm Sci. 2017;4: 96–105.
- 51. Bekele etabalew E, Tadesse T, Negaw R, Zewde T. Magnitude and associated factors of hypertension in Addis Ababa public health facilities, Ethiopia. MOJ Public Heal. 2018;7: 280–286.
- 52. Fikadu G, Lemma S. Socioeconomic Status and Hypertension among Teachers and Bankers in Addis Ababa, Ethiopia. Int J Hypertens. 2016;2016: 4143962–4143967. pmid:27313874
- 53. Nshisso LD, Reese A, Gelaye B, Lemma S, Berhane Y, Williams MA. Prevalence of hypertension and diabetes among Ethiopian adults. Diabetes Metab Syndr Clin Res Rev. 2012;6: 36–41. pmid:23014253
- 54. Abdissa SG, Feleke Y, Awol M. Prevalence of hypertension and pre-hypertension in Addis Ababa, Ethiopia: A survey done in recognition of World Hypertension Day, 2014. Ethiop J Heal Dev. 2015;29: 22–30.
- 55. Angaw K, Dadi AF, Alene KA. Prevalence of hypertension among federal ministry civil servants in Addis Ababa, Ethiopia: a call for a workplace-screening program. BMC Cardiovasc Disord. 2015;15: 76. pmid:26197712
- 56. Abebe S, Yallew WW. Prevalence of hypertension among adult outpatient clients in hospitals and its associated factors In Addis Ababa, Ethiopia: a hospital based cross-sectional study. BMC Res Notes. 2019;12: 1–6.
- 57.
Berhanu Tolera Agama AA. Assessment of prevalence and associated factors of hypertension among outpatient attendants at health centers in Akaki Kality sub-city, Addis Ababa, Ethiopia. Addis Ababa University. 2017.
- 58. Tesfaye F, Byass P, Wall S. Populationbased prevalence of high blood pressure among adults in Addis Ababa: Uncovering a silent epidemic. BMC Cardiovasc Disord. 2009;9. pmid:19698178
- 59. Roba HS, Beyene AS, Mengesha MM, Ayele BH. Prevalence of Hypertension and Associated Factors in Dire Dawa City, Eastern Ethiopia: A Community-Based Cross-Sectional Study. Int J Hypertens. 2019;2019: 9878437–9878439. pmid:31223500
- 60. Bygbjerg IC. Double burden of noncommunicable and infectious diseases in developing countries. Science. 2012. pp. 1499–1501. pmid:22997329
- 61. Mohsen Ibrahim M. Hypertension in Developing Countries: A Major Challenge for the Future. Curr Hypertens Rep. 2018;20. pmid:29717393
- 62. Meiqari L, Essink D, Wright P, Scheele F. Prevalence of Hypertension in Vietnam: A Systematic Review and Meta-Analysis. Asia-Pacific J Public Heal. 2019;31: 101–112. pmid:30678477
- 63. De Ramirez SS, Enquobahrie DA, Nyadzi G, Mjungu D, Magombo F, Ramirez M, et al. Prevalence and correlates of hypertension: A cross-sectional study among rural populations in sub-Saharan Africa. J Hum Hypertens. 2010;24: 786–795. pmid:20220771
- 64. Joshi MD, Ayah R, Njau EK, Wanjiru R, Kayima JK, Njeru EK, et al. Prevalence of hypertension and associated cardiovascular risk factors in an urban slum in Nairobi, Kenya: A population-based survey. BMC Public Health. 2014;14: 1–10.
- 65. Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed hypertension in sub-saharan africa: A systematic review and meta-analysis. Hypertension. 2015;65: 291–298. pmid:25385758
- 66. Bosu WK, Reilly ST, Aheto JMK, Zucchelli E. Hypertension in older adults in Africa: A systematic review and meta-analysis. PLoS One. 2019;14: 1–25. pmid:30951534
- 67. Sarki AM, Nduka CU, Stranges S, Kandala NB, Uthman OA. Prevalence of hypertension in low- and middle-income countries: A systematic review and meta-analysis. Med (United States). 2015;94: 1–16. pmid:26683910
- 68. Adeloye D, Basquill C, Aderemi A V., Thompson JY, Obi FA. An estimate of the prevalence of hypertension in Nigeria: A systematic review and meta-analysis. J Hypertens. 2015;33: 230–242. pmid:25380154
- 69. Pyakurel P, Yadav DK, Thapa J, Thakur N, Sharma P, Koirala N, et al. Prevalence and associated risk factor of hypertension among individuals of age 18–59 years in South-eastern Nepal: A cross-sectional study. Nepal Hear J. 2019;16: 19–26.
- 70. Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, et al. Hypertension in India: A systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32: 1170–1177. pmid:24621804
- 71. Shah N, Shah Q, Shah AJ. The burden and high prevalence of hypertension in Pakistani adolescents: A meta-analysis of the published studies. Arch Public Heal. 2018;76: 1–10. pmid:29619218
- 72. Sanuade OA, Boatemaa S, Kushitor MK. Hypertension prevalence, awareness, treatment and control in Ghanaian population: Evidence from the Ghana demographic and health survey. PLoS One. 2018;13: 1–18. pmid:30403686
- 73. Allender S, Wickramasinghe K, Goldacre M, Matthews D, Katulanda P. Quantifying urbanization as a risk factor for noncommunicable disease. J Urban Heal. 2011;88: 906–918. pmid:21638117
- 74. Htet AS, Bjertness MB, Sherpa LY, Kjøllesdal MK, Oo WM, Meyer HE, et al. Urban-rural differences in the prevalence of non-communicable diseases risk factors among 25–74 years old citizens in Yangon Region, Myanmar: A cross sectional study. BMC Public Health. 2016;16: 1–12.
- 75. Goryakin Y, Rocco L, Suhrcke M. The contribution of urbanization to non-communicable diseases: Evidence from 173 countries from 1980 to 2008. Econ Hum Biol. 2017;26: 151–163. pmid:28410489
- 76. Allender S, Lacey B, Webster P, Rayner M, Deepa M, Scarborough P, et al. Level of urbanization and noncommunicable disease risk factors in Tamil Nadu, India. Bull World Health Organ. 2010;88: 297–304. pmid:20431794
- 77. Jenei Z, Páll D, Katona É, Kakuk G, Polgár P. The epidemiology of hypertension and its associated risk factors in the city of Debrecen, Hungary. Public Health. 2002;116: 138–144. pmid:12082595
- 78. Soubeiga JK, Millogo T, Bicaba BW, Doulougou B, Kouanda S. Prevalence and factors associated with hypertension in Burkina Faso: A countrywide cross-sectional study. BMC Public Health. 2017;17: 1–8.
- 79. Singh Shikha, Shankar Ravi and S GP. Prevalence and Associated Risk Factors of Hypertension: A Cross-Sectional Study in Urban Varanasi. Hinndawi. 2017;2017. pmid:29348933
- 80. Das Gupta R, Bin Zaman S, Wagle K, Crispen R, Hashan MR, Al Kibria GM. Factors associated with hypertension among adults in Nepal as per the Joint National Committee 7 and 2017 American College of Cardiology/American Heart Association hypertension guidelines: a cross-sectional analysis of the demographic and health survey 20. BMJ Open. 2019;9: e030206. pmid:31401611
- 81. Wamala JF, Karyabakabo Z, Ndungutse D, Guwatudde D. Prevalence factors associated with hypertension in Rukungiri District, Uganda—A community-based study. Afr Health Sci. 2009;9: 153–160. pmid:20589143
- 82. Houinato DS, Gbary AR, Houehanou YC, Djrolo F, Amoussou M, Segnon-Agueh J, et al. Prevalence of hypertension and associated risk factors in Benin. Rev Epidemiol Sante Publique. 2012;60: 95–102. pmid:22436411
- 83. Kishore J, Gupta N, Kohli C, Kumar N. Prevalence of Hypertension and Determination of Its Risk Factors in Rural Delhi. Int J Hypertens. 2016;2016. pmid:27127646
- 84. Kannel WB, Vasan RS. Is Age Really a Non-Modifiable Cardiovascular Risk Factor? Am J Cardiol. 2009;104: 1307–1310. pmid:19840582
- 85. Oda E, Kawai R. Body mass index is more strongly associated with hypertension than waist circumference in apparently healthy Japanese men and women. Acta Diabetol. 2010;47: 309–313. pmid:20556442
- 86. Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, et al. Body Mass Index and the Prevalence of Hypertension and Dyslipidemia. Obes Res. 2000;8. pmid:11225709
- 87. Mega TA, Dabe NE. Khat (Catha Edulis) as a Risk Factor for Cardiovascular Disorders: Systematic Review and Meta-Analysis. Open Cardiovasc Med J. 2017;11: 146–155. pmid:29387278
- 88. Al-Motarreb A, Al-Habori M, Broadley KJ. Khat chewing, cardiovascular diseases and other internal medical problems: The current situation and directions for future research. J Ethnopharmacol. 2010;132: 540–548. pmid:20621179
- 89. Getahun W, Gedif T, Tesfaye F. Regular Khat (Catha edulis) chewing is associated with elevated diastolic blood pressure among adults in Butajira, Ethiopia: A comparative study. BMC Public Health. 2010;10: 4–11.
- 90. Birhane BW. The Effect of Khat (Catha edulis) Chewing on Blood Pressure among Male Adult Chewers, Bahir Dar, North West Ethiopia. Sci J Public Heal. 2014;2: 461.
- 91. Patel NB. Mechanism of action of cathinone: The active ingredient of khat (Catha edulis). East Afr Med J. 2000;77: 329–332. pmid:12858935
- 92. Brenneisen R, Fisch H, Koelbing U, Geisshusler S, Kalix P. Amphetamine-like effects in humans of the khat alkaloid cathinone. Br J Clin Pharmacol. 1990;30: 825–828. pmid:2288828
- 93. Balint EE, Falkay G, Balint GA. Khat—A controversial plant. Wien Klin Wochenschr. 2009;121: 604–614. pmid:19921126
- 94. Aladin A, Chevli P, Ahmad MI, Rasool S, Herrington D. Alcohol Consumption and Risk of Hypertension. J Am Coll Cardiol. 2019;73: 12.
- 95. Lang T, Degoulet P, Aime F, Devries C, Jacquinet-Salord MC, Fouriaud C. Relationship between alcohol consumption and hypertension prevalence and control in a French population. J Chronic Dis. 1987;40: 713–720. pmid:3597673
- 96. Saremi A, Hanson RL, Tulloch-Reid M, Williams DE, Knowler WC. Alcohol Consumption Predicts Hypertension but Not Diabetes. J Stud Alcohol. 2004;65: 184–190. pmid:15151348
- 97. Cushman WC. Alcohol Consumption and Hypertension. J Clin Hypertens. 2001;III. pmid:11416702
- 98. Howes LG, Reid JL. The effects of alcohol on local, neural and humoral cardiovascular regulation. Clin Sci. 1986;71: 9–15. pmid:3011352
- 99. Rodríguez-Moran M, Aradillas-García C, Simental-Mendia LE, Monreal-Escalante E, De La Cruz Mendoza E, Dávila Esqueda ME, et al. Family history of hypertension and cardiovascular risk factors in prepubertal children. Am J Hypertens. 2010;23: 299–304. pmid:20075847
- 100. Ranasinghe P, Cooray DN, Jayawardena R, Katulanda P. The influence of family history of Hypertension on disease prevalence and associated metabolic risk factors among Sri Lankan adults Chronic Disease epidemiology. BMC Public Health. 2015;15: 1–9.
- 101. Liu M, He Y, Jiang B, Wang J, Wu L, Wang Y, et al. Association between family history and hypertension among Chinese elderly. Med (United States). 2015;94: 1–6. pmid:26632912